TrademarkDir
PAXEROL
DEAD

Serial Number

86927213

Owner

Wellesley Pharmaceuticals, LLC

Attorney

Michael Ye

First Use Date

May 12, 2015

Filing Date

Mar 3, 2016

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

PAXEROL Trademark

Serial Number: 86927213

PAXEROL is a trademark filed by Wellesley Pharmaceuticals, LLC on March 3, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Wellesley Pharmaceuticals, LLC (6 trademarks)

3 Valley View Dr.
Newtown, PA 18940

Entity Type: 03

Trademark Details

Filing Date

March 3, 2016

Registration Date

Not Registered

First Use Anywhere

May 12, 2015

First Use in Commerce

May 12, 2015

Published for Opposition

March 20, 2018

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Feb 7, 2022 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 7, 2022 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 19, 2021 GNFN
FINAL REFUSAL E-MAILED
Jul 19, 2021 GNFR
SU - FINAL REFUSAL - WRITTEN
Jul 19, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 29, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 29, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 28, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 30, 2020 GNRN
NON-FINAL ACTION E-MAILED
Nov 30, 2020 GNRT
SU - NON-FINAL ACTION - WRITTEN
Nov 30, 2020 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Sep 28, 2020 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 23, 2020 AITU
USE AMENDMENT FILED
Sep 10, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
Sep 10, 2020 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 13, 2020 EXRA
SOU EXTENSION 3 GRANTED
Mar 11, 2020 EX3G
SOU EXTENSION 3 FILED
Mar 11, 2020 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 11, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 24, 2019 EXRA
SOU EXTENSION 2 GRANTED
Aug 22, 2019 EX2G
SOU EXTENSION 2 FILED
Aug 22, 2019 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 22, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 13, 2019 EXRA
SOU EXTENSION 1 GRANTED
Feb 11, 2019 EX1G
SOU EXTENSION 1 FILED
Feb 11, 2019 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 11, 2019 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 6, 2019 TCCA
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 11, 2018 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jul 29, 2018 ETOP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 12, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 12, 2018 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 15, 2018 TCCA
EXTENSION OF TIME TO OPPOSE RECEIVED
Mar 28, 2018 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 20, 2018 NPUB
PUBLISHED FOR OPPOSITION
Mar 20, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 28, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 12, 2018 CNSA
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 10, 2017 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 10, 2017 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 10, 2016 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 10, 2016 GNSL
SUSPENSION LETTER WRITTEN
Aug 10, 2016 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 28, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 28, 2016 CRFA
ASSIGNED TO LIE
Jul 21, 2016 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 18, 2016 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 16, 2016 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 16, 2016 GNSL
SUSPENSION LETTER WRITTEN
Jun 16, 2016 CNSL
ASSIGNED TO EXAMINER
Jun 16, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 8, 2016 NWOS
NEW APPLICATION ENTERED
Mar 7, 2016 NWAP

Related Trademarks

More from this Owner

WELLESLEY PHARMACEUTICALS

WELLESLEY PHARMACEUTICALS

WELLESLEY PHARMACEUTICALS

WELLESLEY PHARMACEUTICALS

WELLESLEY PHARMACEUTICALS

WELLESLEY PHARMACEUTICALS

WELLESLEY PHARMACEUTICALS

WELLESLEY PHARMACEUTICALS

WELLESLEY PHARMACEUTICALS

WELLESLEY PHARMACEUTICALS

NOCTUROL

NOCTUROL